Weekly paclitaxel and carboplatin followed by topotecan (TC-TP), as first-line therapy for patients with advanced epithelial ovarian cancer (AOC) suboptimally debulked. Updated preliminary results

Autor:	M.M. Perez, P. Borrega, Josefina Cruz, R. Gonzalez-Beca, J. A. Arranz Arija, A. Velasco, M. Bolaoos, V. Alija, P. Martinez-Prado, A. Bernal
Rok vydání:	2001
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Weekly paclitaxel Carboplatin chemistry.chemical_compound First line therapy chemistry Internal medicine medicine Epithelial ovarian cancer Topotecan business medicine.drug
Zdroj:	European Journal of Cancer. 37:S260-S261
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(01)81458-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e390e73d6ef9c782adcbdadda0c7b14b https://doi.org/10.1016/s0959-8049(01)81458-1 Zobrazit plný text záznamu Full Text from ScienceDirect